Volume 2, Issue 6: Title of Issue:THE NEW AGENTS FOR DIABETES: THE MEANING OF SAFETY

e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 2, Issue 6)

 

Target Audience

Nurses and health care professionals involved in the care of patients with diabetes.

 

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to describe new findings in:

  • Describe the risks and benefits of incretin-based agents.
  • Evaluate the benefits and safety issues associated with SGLT2 inhibitors.
  • Explain how “safety” of glycemic-control agents should be determined by balancing the longer-term risks of a treatment against its potential benefits.

 

Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Registration opens: 
01/28/2016
Registration closes: 
01/27/2018
Cost:
$0.00
Marc Rendell, MD
Professor of Medicine
Creighton University School of Medicine
Director, Creighton Diabetes Center
Creighton University Medical Center
Omaha, Nebraska
 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.